Filter Results:
(5,072)
Show Results For
- All HBS Web
(5,072)
- People (18)
- News (1,636)
- Research (2,725)
- Events (5)
- Multimedia (109)
- Faculty Publications (1,740)
Show Results For
- All HBS Web
(5,072)
- People (18)
- News (1,636)
- Research (2,725)
- Events (5)
- Multimedia (109)
- Faculty Publications (1,740)
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
- Web
Life at Harvard - Doctoral
option to cross register into courses at the other schools, such as the Harvard Kennedy School, Harvard School of Public Health and MIT; the opportunity to participate in university-wide academic and... View Details
- 22 Nov 2011
- First Look
First Look: November 22
Sephora's traditional marketing programs. Importantly, Bornstein needs to begin thinking about a cohesive long-term strategy that clearly identifies the role digital platforms play and how they help Sephora maintain its leadership... View Details
Keywords: Sean Silverthorne
- 17 Jul 2023
- Blog Post
Sustainability Career Advice from the Career & Professional Development Office
what you were doing before joining HBS and what inspired you to join the Career & Professional Development (CPD) team. Before coming to HBS, I lived in New York City where I worked in integrated View Details
- 13 Jun 2011
- HBS Case
Mobile Banking for the Unbanked
to dig in and figure out what their real needs are and their pain points." The Problem With Wizzit WIZZIT entered the mobile banking market in 2004 because the mobile... View Details
- 26 Aug 2008
- First Look
First Look: August 26, 2008
topic for future research. Download the paper: http://www.hbs.edu/research/pdf/09-016.pdf Stability and Nash Implementation in Matching Markets with Couples Authors:Claus-Jochen Haake, Bettina-Elisabeth... View Details
Keywords: Sean Silverthorne
- 28 Nov 2018
- HBS Case
On Target: Rethinking the Retail Website
jimkruger In the mid-1990s, Target was a discount superstore behemoth. The retailer had set itself apart from chief rival Walmart with a focus on more upscale but wallet-friendly fashion and lifestyle lines, spurring double-digit growth... View Details
- 01 Oct 2013
- First Look
First Look: October 1
champions that the government hoped to create, SPH was also considering an acquisition in the U.S. or Europe. This case allows students to consider the broad trends sweeping China's pharmaceutical industry and View Details
Keywords: Sean Silverthorne
- 27 Jan 2015
- First Look
First Look: January 27
health care providers have devoted significant efforts to improve performance regarding patient safety and quality of care. To address the lagging involvement of health View Details
Keywords: Sean Silverthorne
- 13 Feb 2018
- First Look
New Research and Ideas, February 13, 2018
Case 118-051 Partners In Health: Costing Primary Care in Haiti Partners in Health, a global NGO focused on delivering View Details
Keywords: Sean Silverthorne
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
- 27 May 2009
- First Look
First Look: May 27, 2009
PublicationsDesigning Care: Aligning the Nature and Management of Health Care Author:Richard Bohmer Publication:Harvard Business Press, 2009 Abstract Today's health-care providers face growing criticism—from... View Details
Keywords: Martha Lagace
- 01 Dec 2023
- News
Thinking Ahead
As we wind down 2023, there’s talk everywhere of generative AI and how it will fundamentally alter the world as we know it; but how does that translate for your corner of the business world? Is TikTok something you need to take seriously? (Is it time to dance?) We... View Details
- 30 Sep 2014
- First Look
First Look: September 30
and high levels of press freedom. We further demonstrate that suppliers perform better when they serve buyers located in countries where consumers are wealthy and socially conscious. Taken together, these findings suggest the importance... View Details
Keywords: Sean Silverthorne
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
- 04 Jun 2020
- Book
It’s Not About You: Why Leaders Need to Look Outward
judgment and competence (logic), and when they believe that you care about them (empathy). When trust is lost, it can almost always be traced back to a breakdown in one of these three drivers. You can find... View Details
Keywords: by Kristen Senz
- February 2021 (Revised May 2021)
- Case
SafeGraph: Selling Data as a Service
By: Ramana Nanda, Abhishek Nagaraj and Allison Ciechanover
Set in January 2021, the CEO of SafeGraph, a four-year-old startup that sold Data as a Service, looked to the future. His aim was to become the most trusted source for data about a physical place. The company provided points of interest (POI) and foot traffic data on... View Details
Keywords: Data As A Service; Monetization; Pricing; Business Startups; Analytics and Data Science; Consumer Behavior; Analysis; Business Model; Health Pandemics; Information Industry; United States
Nanda, Ramana, Abhishek Nagaraj, and Allison Ciechanover. "SafeGraph: Selling Data as a Service." Harvard Business School Case 821-082, February 2021. (Revised May 2021.)
- 08 Sep 2010
- First Look
First Look: September 8, 2010
markets, where they were losing market share to the likes of Apple and Samsung, or defend its market leadership in the low-margin, high-volume emerging markets. This case poses... View Details
Keywords: Sean Silverthorne
- January 2017
- Case
Bayer AG: Bidding to Win Merck's OTC Business
By: Benjamin C. Esty, Marc Baaij and Arjen Mulder
Shortly after submitting their best and final offer to acquire Merck's Consumer Care Division (a collection of "over-the-counter" (OTC) products with sales totaling $2 billion), the Bayer M&A team was given a chance to revise their bid because another potential... View Details
Keywords: Acquisition; Bidding Strategy; Valuing Synergies; Negotiations; Corporate Strategy; Business Unit Strategy; Bidding Process; Discounted Cash Flow; Cross-border M&A; Tax Shields; Valuation; Competitive Strategy; Auctions; Bids and Bidding; Germany; United States; United Kingdom
Esty, Benjamin C., Marc Baaij, and Arjen Mulder. "Bayer AG: Bidding to Win Merck's OTC Business." Harvard Business School Case 217-021, January 2017.
- 16 Dec 2020
- Blog Post
My HBS Student Loan Story: Ina Foalea (MBA 2018)
health foundation in Uganda where I was making less but saving more, given my lower expenses. Throughout those years, I was conservative in my spending. I had managed to save... View Details